rss
Br J Ophthalmol 2000;84:40-47 doi:10.1136/bjo.84.1.40
  • Original Article
    • Clinical science

Subthreshold (retinal pigment epithelium) photocoagulation in macular diseases: a pilot study

  1. Johann Roidera,
  2. Ralf Brinkmannc,
  3. Christopher Wirbelauerb,
  4. Horst Laquab,
  5. Reginald Birngruberc
  1. aDepartment of Ophthalmology, University of Regensburg, Regensburg, Germany, bDepartment of Ophthalmology, Medical University of Lübeck, Lübeck, Germany, cMedical Laser Center, Lübeck, Germany
  1. Johann Roider, MD, Augenklinik, Klinikum der Universität Regensburg, Franz-Josef-Strauss Allee 11, D-93053 Regensburg, Germany
  • Accepted 31 August 1999

Abstract

BACKGROUND Subthreshold (retinal pigment epithelium) photocoagulation is a new photocoagulation method, which treats the retinal pigment epithelium (RPE) and avoids damage to the neural retina. The initial results in this prospective pilot study on various macular diseases are presented.

METHODS 12 patients with diabetic maculopathy (group I), 10 with soft drusen (group II), and four with central serous retinopathy (CSR) (group III) were treated and followed up for 1 year. Treatment was achieved using a train of repetitive short laser pulses (1.7 μs) of a green Nd:YLF laser (parameters: 527 nm, 100 and 500 pulses, repetition rate: 500 Hz, spot size: 160 μm, energies: 70–100 μJ). Laser energy was based on the visibility of test lesions on fluorescein angiography (50–130 μJ). Patients were examined at various times by ophthalmoscopy, fluorescein and ICG angiography, and infrared imaging.

RESULTS After 6 months hard exudates disappeared in six out of nine patients in group I and leakage disappeared in six out of 12 diabetic patients. In group II drusen were less in seven out of 10 patients. In group III serous detachment disappeared in three out of four cases. Visual acuity was stable in all cases. None of the laser lesions was clinically visible immediately. After 1 day most lesions were visible as yellowish RPE depigmentation. After 3 months some of the lesions were visible as hyperpigmented areas but most were not. Fluorescein angiography showed leakage only in the first week. Infrared imaging showed that most lesions can be visualised in groups I and II after a period longer than 1 week as hyperreflective areas.

CONCLUSION This study showed that subthreshold (RPE) photocoagulation is effective in some cases of diabetic maculopathy, drusens, and in CSR. Visibility of laser burns is not always necessary in the treatment of macular diseases presented here. Infrared imaging is an effective and non-invasive way of visualising subthreshold (RPE) laser burns.

Footnotes

    This Article

    1. Abstract
    2. Full text
    3. PDF

    Responses

    1. Submit a response
    2. No responses published

    Register for free content

    The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.